Skip to main content

Table 2 Outcome for patients treated with Rifampicin for the full length of treatment (n = 321/411)

From: Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

 

Total

Low-dose

Intermediate-dose

High-dose

Recovery, n (%)

237 (73.8)

10 (55.5)

189 (76.2)

38 (69)

Treatment failure, n (%)

52 (16.2)

5 (27.8)

35 (14.1)

12 (21.8)

Lost to follow-up, n (%)

32 (10)

3 (16.7)

24 (9.7)

5 (9.1)